http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2219818-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0efa077d881a96aeb1e29b21ef1bbb58
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-101
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-103
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06
filingDate 1996-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39becd3a377475c9b38a69e5bd6bcd60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24e0e362c40cd0e06ae38ff019ff9af0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a72063d7f1c9bdcf64d4813b6062ddb
publicationDate 1996-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2219818-A1
titleOfInvention Novel compounds, the preparation and use thereof
abstract Novel dolastatin derivatives of the formula (I): R1R2N-CHX-CO-A-B-D-E-(F)t-K in which R1, R2, A, B, D, E, F, K, X and t have the meanings stated in the description, and the preparation thereof are described. The novel substances have an antineoplastic effect.
priorityDate 1995-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID85286805
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422602897

Total number of triples: 24.